JPRN-jRCTs071190020招募中2 期
Efficacy and safety of triclabendazole for the treatment of fasciolosis - Egaten study
Maruyama Haruhiko0 个研究点目标入组 33 人开始时间: 2019年8月13日最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 33
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- •1) Patients who are diagnosed as having fasciolosis
- •2) Patients who give written informed consent
- •3) Informed consent from proxies are obtained
排除标准
- •1) Patients who are allergic to Triclabendazole
- •2) Patients who are pregnant, or possibly pregnant
- •3) Patients who does not give written informed consent
- •4) Patients principal investigator judged inappropriate
研究者
相似试验
已完成
不适用
Efficacy and safety of fosravuconazole for the treatment of onychomycosis: A multicenter, retrospective studyOnychomycosisJPRN-UMIN000045924Sato Pharmaceutical Co.,Ltd350
已完成
不适用
BENznidazole Evaluation For Interrupting Trypanosomiasis pilot trialInfections and InfestationsParasitical diseasesAmerican trypanosomiasisChagas diseaseISRCTN13967269Hamilton Health Science Corporation (HHSC) (Canada)600
已完成
不适用
Safety and efficacy study of Triphala and Trimad in obseityCTRI/2017/11/010409Interactive Research school for health Affairs120
招募中
不适用
Tailored therapy of Helicobacter pylori infectioKCT0003563Kangdong Sacred Heart Hospital660
已完成
不适用
Efficacy and safety of praziquantel, tribendimidine and mebendazole in patients infected with Clonorchis sinensisClonorchiasisInfections and InfestationsISRCTN55086560The National Institute of Parasitic Diseases (China)120